Parnell Expands Veterinary Anesthesia Portfolio with Isoflurane

News > Health News

Audio By Carbonatix

6:13 AM on Tuesday, January 6

The Associated Press

OVERLAND PARK, Kan.--(BUSINESS WIRE)--Jan 6, 2026--

Parnell is proud to announce the launch of its new Isoflurane Inhalation Anesthetic, a nonflammable and nonexplosive solution designed for the induction and maintenance of general anesthesia in horses and dogs.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106461468/en/

Parnell Isoflurane Inhalation Anesthetic

Available in 250 mL bottles, Parnell’s Isoflurane provides veterinary clinics with a reliable, cost-effective alternative to existing options, ensuring safe and efficient anesthesia care.

“We are pleased to introduce Isoflurane as part of Parnell’s continued commitment to advancing pet specialty care through dependable, high-quality anesthesia and sedation solutions,” said Pablo Lamberto, DVM, SVP and President of U.S. Operations for Parnell. “Isoflurane reflects our focus on delivering consistent clinical performance while enabling veterinary teams to manage costs responsibly without ever compromising the safety, comfort, or quality of care their patients deserve.”

Key Features:

Rapid induction and recovery
Nonflammable and nonexplosive
Convenient 250 mL packaging

Isoflurane complements Parnell’s robust anesthesia and sedation portfolio, which includes PropofolVet Multidose (propofol injectable emulsion), Parnell Brand Dexmedetomidine Hydrochloride Injection, and CONTRASED™ (atipamezole hydrochloride). To further support veterinary success, Parnell offers the Foundations of Anesthesia & Sedation Certificate Program, an online course providing 10 RACE-approved CE hours. Learn more at parnell.com/education. Together, these solutions provide veterinary professionals with a comprehensive toolkit to manage anesthesia and sedation protocols across a wide range of clinical scenarios, ensuring safety, efficiency, and optimal patient outcomes.

For more information, visit parnell.com or contact your local distributor representative.

About Parnell

Parnell is a fully integrated, veterinary pharmaceutical company focused on developing, manufacturing and commercializing innovative animal health solutions. We currently manufacture and market products for companion and production animals in 10 countries. Discover more at www.parnell.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260106461468/en/

CONTACT: Media Contact:

Angela Kille

Associate Director of Strategic Marketing

[email protected]

913-274-2100

KEYWORD: KANSAS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: PHARMACEUTICAL HEALTH VETERINARY

SOURCE: Parnell

PUB: 01/06/2026 09:13 AM/DISC: 01/06/2026 09:13 AM

http://www.businesswire.com/news/home/20260106461468/en